skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Polyvalent immunogen

Patent ·
OSTI ID:936107

The present invention relates, generally, to a polyvalent immunogen and, more particularly, to a method of inducing neutralizing antibodies against HIV and to a polyvalent immunogen suitable for use in such a method.

Research Organization:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
W-7405-ENG-36
Assignee:
Duke University (Durham, NC); The Regents of The University of California (Oakland, CA)
Patent Number(s):
7,172,761
Application Number:
10/431,596
OSTI ID:
936107
Country of Publication:
United States
Language:
English

References (4)

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen journal January 1998
HIV Vaccine Development at Duke University Medical Center journal January 2000
HIV Type 1 V3 Region Primer-Induced Antibody Suppression Is Overcome by Administration of C4-V3 Peptides as a Polyvalent Immunogen journal February 1995
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses journal August 2000